Keywords
Coronary Artery Disease ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
Selected data models

You must log in to select data models for download or further analysis.

287 Search results.

ICHOM Coronary Artery Disease - Peri-Inverventional Clinical Form

- 11/22/18 - 1 form, 8 itemgroups, 46 items, 1 language
Itemgroups: Administrative Data, Demographic factors, Baseline health status, Prior Treatments, TREATMENT VARIABLES, Acute complications of treatment, Major surgery complications, Major interventional cardiology complications
CORONARY ARTERY DISEASE DATA COLLECTION Version 2.0.3 Revised: April 5th, 2017 International Consortium for Health Outcomes Measurement (ICHOM), Source: http://www.ichom.org/ Conditions: Asymptomatic Coronary Artery Disease | Stable Angina | Acute Coronary Syndrome (Includes AMI) Treatment Approaches: Lifestyle Modification | Drug Therapy | Percutaneous Coronary Intervention (PCI) | Coronary Artery Bypass Grafting (CABG) This form contains peri-interventional clinical items. The items cover a timespan from prior to the intervention (e.g. PCI or CABG) until 30 days after it. They should be assessed at the entry event and at any new index event (e.g. new revascularization procedure or new diagnosis of ACS). Questionnaires used in this standard set: Rose Dyspnea Scale: The Rose Dyspnea Scale is free for all health care organizations, and a license is not needed. More information may be found at http://www.ahjonline.com/article/S0002-8703(09)00266-X/abstract Patient Health Questionnaire (PHQ-2): The PHQ-2 is free for all health care organizations, and a license is not needed. Copyright Pfizer, more Information on http://www.phqscreeners.com/ Seattle Angina Questionnaire (SAQ-7): Due to the need for a license for use of the SAQ-7 the actual questions of SAQ-7 will not be part of this version of the standard set. Publication: McNamara RL, Spatz ES, Kelley TA, et al. Standardized Outcome Measurement for Patients With Coronary Artery Disease: Consensus From the International Consortium for Health Outcomes Measurement (ICHOM). J Am Heart Assoc. 2015;4(5):e001767. Published 2015 May 19. doi:10.1161/JAHA.115.001767

Eligibility CAD NCT01406990

- 10/22/19 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Aspirin Responsiveness in Women With Coronary Artery Disease; ODM derived from: https://clinicaltrials.gov/show/NCT01406990

Eligibility Multivessel Coronary Artery Disease NCT02226900

- 5/20/19 - 1 form, 2 itemgroups, 17 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Myocardial Hybrid Revascularization Versus Coronary artERy Bypass GraftING for Complex Triple-vessel Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02226900

Eligibility Coronary Artery Disease NCT02515825

- 3/12/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Angiographic Comparison in an Observational Study of CADence (The AMBIENCE Study); ODM derived from: https://clinicaltrials.gov/show/NCT02515825

Eligibility Coronary Artery Disease NCT02513810

- 3/11/19 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Randomized Controlled Comparison Between One Versus More Than Six Months of Dual Antiplatelet Therapy After Biolimus A9-eluting Stent Implantation; ODM derived from: https://clinicaltrials.gov/show/NCT02513810

Eligibility Coronary Artery Disease NCT02496234

- 3/11/19 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
The Use of Aging Biomarkers to Predict Adverse Outcomes After Cardiac Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT02496234

Eligibility Coronary Artery Disease NCT02493205

- 3/11/19 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
The Holding Area LINQ (Reveal LINQ Insertable Cardiac Monitor) Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial; ODM derived from: https://clinicaltrials.gov/show/NCT02493205

Eligibility Coronary Artery Disease NCT02480348

- 3/11/19 - 1 form, 2 itemgroups, 13 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Medtronic RevElution Trial; ODM derived from: https://clinicaltrials.gov/show/NCT02480348

Eligibility Coronary Artery Disease NCT02475291

- 3/11/19 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Clinical Usefulness of Fractional Flow Reserve Measurement for Significant Stenosis in Proximal Coronary Artery; ODM derived from: https://clinicaltrials.gov/show/NCT02475291

Eligibility Coronary Artery Disease NCT02466282

- 3/11/19 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Comparison of Optical Coherence Tomography Guidance and Angiography-only Guidance for Percutaneous Coronary Intervention With Bioresorbable Vascular Scaffold; ODM derived from: https://clinicaltrials.gov/show/NCT02466282

Eligibility Coronary Artery Disease NCT02457130

- 3/11/19 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM); ODM derived from: https://clinicaltrials.gov/show/NCT02457130

Eligibility Coronary Artery Disease NCT02443402

- 3/10/19 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery; ODM derived from: https://clinicaltrials.gov/show/NCT02443402